NextCure NXTC
NASDAQ NXTC
$4.90 +0.29 (+6.30%)
As of: Oct 23, 2026 · 3:52 PM EDT

NextCure (NXTC) Net Preferred Shares Issued and Repurchased (2018)

Updated

NextCure's Net Preferred Shares Issued and Repurchased was $91.22 million in Q4 2018.

Analysis

NextCure (NXTC) Net Preferred Shares Issued and Repurchased (2018) Analysis & Trends

For FY2018, Net Preferred Shares Issued and Repurchased at NextCure came in at $122.22 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Pref. Shares Issued (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn -
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn -
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn -
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn -
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn -
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn -
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn -
10 NextCure 26.02 Mn -94.74 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 91.22 Mn
API Access

NextCure Net Preferred Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-preferred-shares-issued-and-repurchased&ticker=NXTC&period=max&api_key=YOUR_API_KEY